Stock listing

Shield Therapeutics Plc

Selected listing: STX · LSE · GBX · GB

Shield Therapeutics Plc (LSE:STX), Health Technology. Latest release Sep 30, 2026: Total Voting Rights.

STX:LSEGBXGBUpdated October 2, 2026

Ticker: LSE:STX
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LSE
Currency: GBX

About Shield Therapeutics Plc

Shield Therapeutics Plc is a public company listed on the UK market under the ticker STX. Shield Therapeutics focuses on developing and commercializing innovative pharmaceutical products.

Latest news from Shield Therapeutics Plc

Total Voting Rights

September 30, 2026

Shield assumes full control of ACCRUFeR® in the US

August 27, 2026

Interim results for the six months ended 30 Jun 26

August 20, 2026

Q2 and H1 2026 Trading Update

July 30, 2026

ACCRUFeR® Phase 3 pediatric trial published

July 28, 2026

All Shield Therapeutics Plc news →

Events

Replays

SHIELD THERAPEUTICS PLC (STX) — Q4 2025 Trading Update
Thu, Jan 22, 2026 · 09:00 AM ET
Watch
SHIELD THERAPEUTICS PLC (STX) — Q3 Trading Update
Thu, Oct 23, 2025 · 10:00 AM ET
Watch
SHIELD THERAPEUTICS PLC (STX) — Q2 trading update
Wed, Jul 23, 2025 · 10:00 AM ET
Watch

Research Shield Therapeutics Plc

Shield Therapeutics Plc company profile

View the public company page for Shield Therapeutics Plc on 6ix.

Shield Therapeutics Plc news

Read company news and market updates connected to Shield Therapeutics Plc.

Shield Therapeutics Plc investor events

Find investor webinars, events, and replay context for Shield Therapeutics Plc.